In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Reference Laboratories Inc.

Division of Opko Health Inc.
www.bioreference.com

Latest From Bio-Reference Laboratories Inc.

The Frost Factor: An M&A Leader's Standout Strategy For Opko Health

With CEO leadership in the biopharma industry more short-cycled than ever, billionaire entrepreneur Phillip Frost ranks as a competitor for the long game – the last man standing in an endurance test spanning four decades of exposure to every iteration of a fast-changing business model. Frost’s strategy at Opko eschews the approach of most of his CEO peers to seek therapeutic dominance in a narrow band of core competencies.

Business Strategies Deals

Execs On The Move, April 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q4 2015

At $1.2 billion, Q4 device financing was the second-lowest quarter of 2015; M&A dollar volume was also low, but included multiple deals across various cardiovascular markets. Diagnostics financing was also down in Q4, totaling $403 million; acquisitions were worth $441 million.

Medical Device Deals

Deals In Depth: June/July 2015

Sanofi and Regeneron teamed up in a second major deal, focused on immuno-oncology; after an unsuccessful try at Mylan, Teva bought Allergan's generics business. Between June and July, biopharma companies raised over $10 billion, and device firms more than $1 billion.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
    • Urine-based Testing
  • Laboratory Testing Services
    • Anatomical Pathology
    • Esoteric Laboratories
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Opko Health Inc.
  • Senior Management
  • Nicholas Papazicos, SVP, Secretary-Treasurer, CFO
    Gregory Henderson, MD, PhD, Pres.
    Charles, Jr. T Todd, SVP, Sales & Mktg.
    James Weisberger, MD, SVP, CMO
  • Contact Info
  • Bio-Reference Laboratories Inc.
    Phone: (201) 791-2600
    481-B Edward H. Ross Dr.
    Elmwood Park, NJ 07407
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register